Assignee

AXSOME THERAPEUTICS INC

US·138 granted patents·68 pending applications·6,582 citations·filing 2016–2025

Technology mixA61K206 A61P154 C08B100 C08L39 B82Y3 C07D2

Top patents by PatentIndex Score

206 records

0199US12551489B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Feb 17, 2026·1 cites·23 claims
0299US12551488B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Feb 17, 2026·1 cites·23 claims
0399US12485176B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Dec 2, 2025·2 cites·17 claims
0499US12478678B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 25, 2025·1 cites·20 claims
0599US12472256B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·20 claims
0699US12472258B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·20 claims
0799US12472257B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Nov 18, 2025·1 cites·20 claims
0899US12447155B2Use of reboxetine to treat narcolepsyAXSOME THERAPEUTICS INC·Filed 2025·Granted Oct 21, 2025·1 cites·16 claims
0999US12246023B2Use of reboxetine to treat narcolepsyAXSOME THERAPEUTICS INC·Filed 2023·Granted Mar 11, 2025·10 cites·13 claims
1099US12156914B2Pharmaceutical compositions comprising bupropion and cysteineAXSOME THERAPEUTICS INC·Filed 2023·Granted Dec 3, 2024·23 cites·17 claims
1199US12128052B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·13 cites·18 claims
1299US12005118B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Jun 11, 2024·13 cites·28 claims
1399US11944683B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Apr 2, 2024·17 cites·30 claims
1499US11865117B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·22 cites·24 claims
1599US11826354B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2023·Granted Nov 28, 2023·17 cites·25 claims
1699US11826370B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Nov 28, 2023·17 cites·14 claims
1799US11759522B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Sep 19, 2023·23 cites·20 claims
1899US11738085B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·23 cites·29 claims
1999US11712441B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Aug 1, 2023·25 cites·18 claims
2099US11660273B2Dosage forms and methods for enantiomerically enriched or pure bupropionAXSOME THERAPEUTICS INC·Filed 2022·Granted May 30, 2023·39 cites·19 claims
2199US11660274B2Dosage forms and methods for enantiomerically enriched or pure bupropionAXSOME THERAPEUTICS INC·Filed 2022·Granted May 30, 2023·39 cites·19 claims
2299US11628173B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Apr 18, 2023·26 cites·19 claims
2399US11617755B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Apr 4, 2023·24 cites·27 claims
2499US11617756B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Apr 4, 2023·27 cites·28 claims
2599US11617791B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Apr 4, 2023·34 cites·30 claims
2699US11607456B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Mar 21, 2023·26 cites·17 claims
2799US11602563B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Mar 14, 2023·24 cites·29 claims
2899US11571428B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Feb 7, 2023·29 cites·30 claims
2999US11510927B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Nov 29, 2022·35 cites·19 claims
3099US11504429B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Nov 22, 2022·32 cites·9 claims
3199US11471465B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2022·Granted Oct 18, 2022·37 cites·30 claims
3299US11471464B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Oct 18, 2022·33 cites·20 claims
3399US11433078B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Sep 6, 2022·38 cites·30 claims
3499US11433079B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Sep 6, 2022·37 cites·30 claims
3599US11426414B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Aug 30, 2022·35 cites·26 claims
3699US11369684B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Jun 28, 2022·39 cites·24 claims
3799US11357854B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Jun 14, 2022·42 cites·26 claims
3899US11331323B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted May 17, 2022·43 cites·18 claims
3999US11285215B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Mar 29, 2022·52 cites·26 claims
4099US11285213B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Mar 29, 2022·42 cites·27 claims
4199US11285214B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Mar 29, 2022·41 cites·29 claims
4299US11266657B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2020·Granted Mar 8, 2022·47 cites·26 claims
4399US11219626B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2020·Granted Jan 11, 2022·51 cites·17 claims
4499US11207328B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Dec 28, 2021·50 cites·26 claims
4599US11207327B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Dec 28, 2021·45 cites·21 claims
4699US11185550B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Nov 30, 2021·55 cites·25 claims
4799US11135295B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Oct 5, 2021·47 cites·30 claims
4899US11129895B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Sep 28, 2021·46 cites·29 claims
4999US11123431B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2021·Granted Sep 21, 2021·46 cites·30 claims
5099US11110173B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·48 cites·28 claims

Showing the top 50 of 206 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when AXSOME THERAPEUTICS INC files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →